MiR-92a/DUSP10/JNK signalling axis promotes human pancreatic cancer cells proliferation

Biomedicine and Pharmacotherapy

Volumn 68, Issue 1, 2014, Pages 25-30

  He, Gengsheng ^a,b   Zhang, Lei ^c   Li, Qing ^d   Yang, Longqiu ^e  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b UNIVERSITY OF SOUTH CHINA   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^d Jiangsu Provincial Hospital of Integrated Traditional Chinese and Western Medicine   (China)

^e ZHENGZHOU UNIVERSITY   (China)

Author keywords

DUSP10; MiR 92a; Pancreatic cancer; Proliferation

Indexed keywords

DUSP10; MIR-92A; PANCREATIC CANCER; PROLIFERATION;

CELL LINE, TUMOR; CELL PROLIFERATION; DUAL-SPECIFICITY PHOSPHATASES; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MALE; MICRORNAS; MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASES; PANCREATIC NEOPLASMS; SIGNAL TRANSDUCTION;

EID: 84895070655     PISSN: 07533322     EISSN: 19506007     Source Type: Journal    
DOI: 10.1016/j.biopha.2013.11.004     Document Type: Article

References (29)

1. Hirata K., Egawa S., Kimura Y., Nobuoka T., Oshima H., Katsuramaki T., et al. Current status of surgery for pancreatic cancer. Dig Surg 2007, 24:137-147.
2. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J. Cancer statistics, 2003. CA Cancer J Clin 2003, 53:5-26.
3. Hawes R.H., Xiong Q., Waxman I., Chang K.J., Evans D.B., Abbruzzese J.L. A multispecialty approach to the diagnosis and management of pancreatic cancer. Am J Gastroenterol 2000, 95:17-31.
4. Matsuno S., Egawa S., Fukuyama S., Motoi F., Sunamura M., Isaji S., et al. Pancreatic cancer registry in Japan: 20years of experience. Pancreas 2004, 28:219-230.
5. Kenoki Ohuchida, Kazuhiro Mizumoto, Cui Lin, Hiroshi Yamaguchi, Takao Ohtsuka, et al. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. Ann Surg Oncol 2012, 19:2394-2402.
6. Garzon R., Fabbri M., Cimmino A., Calin G.A., Croce C. MicroRNAs expression and function in cancer. Trends Mol Med 2006, 12:580-587.
7. Bracken C.P., Gregory P.A., Khew-Goodall Y., Goodall G.J. The role of microRNAs in metastasis and epithelial-mesenchymal transition. Cell Mol Life Sci 2009, 10:1682-1699.
8. Esquela-Kerscher A., Slack F.J. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006, 6:259-269.
9. Liu T., Tang H., Lang Y., Liu M., Li X. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin. Cancer Lett 2009, 273:233-242.
10. Huang Q., Gumireddy K., Schrier M., le Sage C., Nagel R., et al. The microRNAs miR-373 and miR-520c promote tumour invasion and metastasis. Nat Cell Biol 2008, 10:202-210.
11. Lee R.C., Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294:862-865.
12. Lagos-Quintana M., Rauhut R., Lendeckel W., Tuschl T. Identification of novel genes coding for small expressed RNAs. Science 2001, 294:853-858.
13. Lau N.C., Lim L.P., Weinstein E.G., Bartel D.P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science 2001, 294:858-862.
14. Wang W.S., Liu L.X., Li G.P., et al. Combined serum CA19-9 and miR-27a-3p in peripheral blood mononuclear cells to diagnose pancreatic cancer. Cancer Prev Res (Phila) 2013, 6:331-338.
15. Baraniskin A., Nöpel-Dünnebacke S., Ahrens M., et al. Circulating U2 small nuclear RNA fragments as a novel diagnostic biomarker for pancreatic and colorectal adenocarcinoma. Int J Cancer 2013, 132:E48-E57.
16. Morimura R., Komatsu S., Ichikawa D., et al. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. Br J Cancer 2011, 105:1733-1740.
17. Liu J., Gao J., Du Y., et al. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer 2012, 131:683-691.
18. Liu R., Chen X., Du Y., et al. Serum microRNA expression profile as a biomarker in the diagnosis and prognosis of pancreatic cancer. Clin Chem 2012, 58:610-618.
19. Takahashi R., Hirata Y., Sakitani K., Nakata W., Kinoshita H., et al. Therapeutic effect of c-Jun N-terminal kinase inhibition on pancreatic cancer. Cancer Sci 2013, 104:337-344.
20. Kennedy N.J., Davis R.J. Role of JNK in tumor development. Cell Cycle 2003, 2:199-201.
21. Nateri A.S., Spencer-Dene B., Behrens A. Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development. Nature 2005, 437:281-285.
22. Yunoki T., Kariya A., Kondo T., Hayashi A., Tabuchi Y. The combination of silencing BAG3 and inhibition of the JNK pathway enhances hyperthermia sensitivity in human oral squamous cell carcinoma cells. Cancer Lett 2013, 335:52-57.
23. Shibata W., Maeda S., Hikiba Y., et al. c-Jun NH2-terminal kinase 1 is a critical regulator for the development of gastric cancer in mice. Cancer Res 2008, 68:5031-5039.
24. Sakurai T., Maeda S., Chang L., Karin M. Loss of hepatic NF-kappa B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase1 activation. Proc Natl Acad Sci USA 2006, 103:10544-10551.
25. Hui L., Zatloukal K., Scheuch H., Stepniak E., Wagner E.F. Proliferation of human HCC cells and chemically induced mouse liver cancers requires JNK1-dependent p21 downregulation. J Clin Invest 2008, 118:3943-3953.
26. Chen F., Castranova V. Beyond apoptosis of JNK1 in liver cancer. Cell Cycle 2009, 8:1145-1147.
27. Chen N., Nomura M., She Q.B., et al. Suppression of skin tumorigenesis in c-Jun NH(2)-terminal kinase-2-deficient mice. Cancer Res 2001, 61:3908-3912.
28. Harald Ehrhardt, Simone Fulda, Irene Schmid, John Hiscott, laus-Michael Debatin, Irmela Jeremias TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-B. Oncogene 2003, 22:3842-3852.
29. Mapara M.Y., Bargou R., Zugck C., Dohner H., Ustaoglu F., Jonker R.R., et al. APO-1 mediated apoptosis or proliferation in human chronic B lymphocytic leukemia: correlation with bcl-2 oncogene expression. Eur J Immunol 1993, 23:702-708.